机译:生物标志物发现分析:Nevi,皮肤黑素瘤和转移性黑素瘤的P14,P16,P53和BAP1表达的改变
Department of Pathology Stanford University Medical Center Stanford California;
Department of Pathology Stanford University Medical Center Stanford California;
Department of Dermatology Stanford University Medical Center Stanford California;
Department of Pathology Stanford University Medical Center Stanford California;
Department of Pathology Stanford University Medical Center Stanford California;
Department of Dermatology Stanford University Medical Center Stanford California;
Department of Pathology Stanford University Medical Center Stanford California;
BAP1; biomarker; melanoma; p14ARF; p16; p53; prognosis;
机译:生物标志物发现分析:Nevi,皮肤黑素瘤和转移性黑素瘤的P14,P16,P53和BAP1表达的改变
机译:p53途径和p16INK4a表达的改变预示了达卡巴嗪治疗的转移性黑色素瘤患者的总生存期。
机译:在原发性皮肤恶性黑色素瘤,皮肤恶性黑色素瘤转移和良性黑素细胞痣中microRNA表达谱的比较微阵列分析
机译:在英国使用肿瘤浸润淋巴细胞的制造和临床结果,英国在英国中的转移皮肤,防御性和粘膜黑素瘤
机译:使用图像分析检测和分类恶性黑色素瘤和发育不良痣:一种视觉纹理方法。
机译:胚芽BAP1失活优选与转移性眼黑素瘤和皮肤眼黑素瘤家族相关。
机译:p53途径和p16INK4a表达的变化预测达卡巴嗪治疗的转移性黑素瘤患者的总体生存率